ImThera Medical Inc has been named winner of the Gold Electrode Award in the Best New Product category for its aura6000 THN Sleep Therapy System, a system for the treatment of obstructive sleep apnea (OSA). The Gold Electrode Award is presented at the annual Neurotech Leaders Forum to recognize products that experts believe have the greatest potential to impact on the neuroscience industry.
The aura6000 was selected by editors from Neurotech Reports for its proprietary targeted hypoglossal neurostimulation (THN) sleep therapy. The system represents a novel treatment alternative to conventional CPAP for patients suffering from OSA.
“We are pleased to recognize ImThera’s aura6000 as the Best New Product for its innovative therapy for obstructive sleep apnea,” said James Cavuoto, editor of Neurotech Reports. “Though there are several new neurostimulation devices competing in the market for treating OSA, we selected ImThera’s aura6000 because of its ability to deliver targeted hypoglossal nerve stimulation to achieve optimal muscle stimulation.”